Republicans Say They’ve Found Evidence Of Possible Illegal Conduct Over Fetal Tissue Profits
The Democrats, however, say the report is based on documents that were obtained illegally, and have led to "inaccurate and misleading" conclusions.
The independent source for health policy research, polling, and news.
38,021 - 38,040 of 112,572 Results
The Democrats, however, say the report is based on documents that were obtained illegally, and have led to "inaccurate and misleading" conclusions.
Lab conditions and the risk of contamination were determined to not be suitable to produce clinical-study drugs at two facilities. No evidence of patient harm has been found.
The Centers for Medicare and Medicaid Services sent a letter to all 50 states warning them that ending funding is tantamount to restricting access to a qualified provider, which goes against the law.
The bill has a provision to sunset the state's Medicaid expansion program, but the governor has pledged to use his line-item veto on that measure, thus insuring the program will be funded and continue.
The insurer's exchange business was relatively small, but the move draws attention to the industry's struggle to adjust to the sicker, more costly pool of customers that have dominated the market under the Affordable Care Act.
Today's early morning highlights from the major news organizations.
A selection of opinions from around the country.
A selection of opinions from around the country.
Dr. Daniel Rubens is launching a two-year study that focuses on how inner ear defects may lead to Sudden Infant Death Syndrome. Elsewhere, a new study adds to growing research that the HPV vaccine is underutilized, Pennsylvania researchers make strides toward a treatment for a rare genetic disease, a report on the impact of Colorado's marijuana law is out, and a health survey out of North Carolina suggests e-cigarette use is still on the rise in the state's schools.
As patients are getting stuck with bank-breaking costs for the life-saving rides, lawmakers are trying to get rules in place to regulate the industry. But their efforts have been blocked along the way.
The legislature did not approve the governor's full funding for the program, and officials have said cuts will need to be made in Medicaid. Also in the news is a look at a report prepared for the North Carolina legislature about problems implementing changes in the state's Medicaid program.
The appellants can still ask a larger panel of judges at the Third Circuit to hear their appeal, or they can solicit the Supreme Court, but legal experts say both would be a long shot.
Meanwhile, Democrats are urging Senate Republicans to act and appropriate money to fight the virus before its too late.
A year later, 88 percent of the people in the study who were given a cell transplant were free of severe hypoglycemia events, had their awareness of blood sugar dips restored and harbored glucose levels in near-normal ranges.
The report, released by the Government Accountability Office, comes just before a House Veterans Affairs’ Committee hearing on the issue. “This report proves what we’ve long known: wait-time manipulation continues at VA and the department’s wait-time rhetoric doesn’t match up with the reality of veterans’ experiences,” Rep. Jeff Miller (R-Fla.), the committee chairman says.
Roche Holding shelved a cholesterol drug after a late-stage study found disappointing results. But Roche's loss is DalCor's gain, as the startup announces a 5,000 patient trial to test its theory that a genetic variation is key to making the drug a success. Meanwhile, Roche has reported an increase in its first quarter revenue.
About 375,000 people in Louisiana are expected to enroll in the program for low-income residents. At the same time, officials in Arkansas continue wrestling with the governor's plan to end the political impasse over expansion.
House Energy and Commerce Committee Chairman Fred Upton, R-Mich., says his four-member task force, charged with finding a replacement plan to the Affordable Care Act, is close to a Republican alternative.
The nonpartisan Medicare Payment Advisory Commission says incentives are needed to encourage insurance providers to push for bigger pharmaceutical discounts and manage prescription use. Meanwhile, according to an AARP survey, older Americans also strongly favor a federal role in negotiating Medicare discounts.
But the insurer's anticipated further retreat from the health law's marketplaces could pose difficulties for consumers.
© 2026 KFF